Eunice Wang, MD

Chief, Leukemia Service, Department of Medicine

Roswell Park Comprehensive Cancer Center
Buffalo, New York
Wang-Eunice

Eunice Wang, MD

Chief, Leukemia Service, Department of Medicine

Roswell Park Comprehensive Cancer Center
Buffalo, New York

Biography

Eunice Wang, MD, is a board-certified hematology and medical oncology physician, Professor of Oncology, Assistant Member in the Department of Tumor Immunology, Chief of Clinical Leukemia Service, and Medical Director and Physician Leader of the Chemotherapy/Infusion Center at the Roswell Park Comprehensive Cancer Center in Buffalo. Dr Wang is also an Associate Professor in the Department of Medicine at the State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences.

She serves in multiple leadership roles including Co-Chair of the Leukemia Translational Research Group and Director of the Hematologic Procurement Shared Resource Pathology Resource Network at Roswell Park Comprehensive Cancer Center. She serves on the Acute Myeloid Leukemia and Acute Lymphocytic Leukemia Clinical Practice Guidelines Panels for the National Comprehensive Cancer Network and the Leukemia Correlative Sciences and Leukemia Core Committees for the Alliance Cooperative Cancer Clinical Trials Group. Dr. Wang is an Editorial Board member of Best Practice and Research Clinical Haematology; Clinical Lymphoma, Myeloma & Leukemia; Blood Advances; and Leukemia Research Reports. She is the recipient of a Cancer Clinical Investigator Team Leadership Award given by the National Cancer Institute/National Institutes of Health (2013).

Dr. Wang has published at least 131 peer-reviewed articles and at least 13 book chapters. She is an active member of the Children’s Oncology Group, the European Hematology Association, the Society of Hematologic Oncology, the American Association of Internal Medicine, the American Society of Clinical Oncology, the American Society of Hematology, and the American Association of Cancer Research. Dr. Wang’s clinical research focus includes acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndromes.